Need Help?

CUP-COMP Single tissue-only sample data

BAM and FASTQ runs and VCF analysis of WGS analysis of single sample that had tissue only collection.

Request Access

DUO:0000006
version: 2021-02-23

health or medical or biomedical research

This data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry.

DUO:0000019
version: 2021-02-23

publication required

This data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.

DUO:0000021
version: 2021-02-23

ethics approval required

This data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

DUO:0000028
version: 2021-02-23

institution specific restriction

This data use modifier indicates that use is limited to use within an approved institution.

CUP-COMP Data Access Committee Policy

At the Christie NHS Foundation Trust we are committed to making research data available to other researchers wherever possible. The CUP-COMP study was funded by Innovate UK and the sharing of data is in line with the UKRI policy. The chief investigator is substantively employed by The University of Manchester and conducts research in accordance with the institution’s Code of Good Research Conduct. This study was sponsored by The Christie NHS Foundation Trust. The sharing of research data obtained from Christie sponsored studies outside of the regulatory approved study is compliant with the Trust’s information sharing policy. In accordance with this policy, the requesting lead applicant is required to complete a data release request form. To access study data for this Christie sponsored study, we ask that the requestor contact the data access committee to obtain the current version of the study data release request form. The study team will be asked to complete the study data request form and return this to the data access committee administrator. In accordance with the best practice guidance for data access committees as published by the EGA, additional checks may be performed by the Trust to verify the institution and identity of the requestor. The request will be reviewed by a data access review panel which includes representation form the CUP COMP study team, study sponsor and information governance representation from the Trust. The requestor must also agree to the terms and conditions set out in the data access agreement and if applicable any overarching research agreement with The Christie. Following signature of the relevant agreements, the data access committee will approve the release of the requested data.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000001821 Cancer Genomics

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF50000833745 bam 55.8 GB
EGAF50000833764 bam 150.0 GB
EGAF50000833810 fastq.gz 85.5 GB
EGAF50000833811 fastq.gz 87.1 GB
EGAF50000833982 vcf.gz 42.7 kB Report
EGAF50000833983 vcf.gz 1.8 MB Report
EGAF50000833984 vcf.gz 2.0 kB Report
EGAF50000833985 vcf.gz 26.5 kB Report
EGAF50000833986 vcf.gz 2.1 MB Report
9 Files (378.3 GB)